Under construction – not a live service
Sign in

Fatty liver disease (MASLD/MASH): open trials in China

73 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT07145151

    A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Trial Treatment · Phase 2 · The United Bio-Technology (Hengqin) Co., Ltd.

    Beijing Tsinghua Changgung Hospital, Beijing

    Registry updated 2026-11-03

  • NCT07850063

    ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

    Trial Treatment · Phase 3 · Boehringer Ingelheim

    West China Hospital,Sichuan University, Chengdu · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Shanghai Tenth People's Hospital, Shanghai · Zhongshan Hospital Affiliated to Fudan University, Shanghai

    Registry updated 2026-10-30

  • NCT06632444

    LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

    Trial Treatment · Phase 3 · Boehringer Ingelheim

    Beijing Tsinghua Changgung Hospital, Beijing · Beijing YouAn Hospital,Capital Medical University, Beijing · Beijing Friendship Hospital, Beijing · Peking University People's Hospital, Beijing · Beijing Ditan Hospital, Capital Medical University, Beijing · The First Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · Hunan Provincial People's Hospital, Changsha · Changzhou Third People's Hospital, Changzhou Shi · West China Hospital,Sichuan University, Chengdu · Chongqing Three Gorges Central Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou · Guangzhou First People's Hospital, Guangzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · Nanfang Hosptial, Guangzhou · Guizhou Provincial People's Hospital, Guiyang · Zhejiang Hospital, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The Affiliated Hospital of Hangzhou Normal University, Hangzhou · The First Affiliated Hospital, Zhejiang University, Hangzhou · The First Hospital Of Jiaxing, Jiaxing · Liaocheng People's Hospital, Liaocheng · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The First Affiliated Hospital of NanChang University, Nanchang · The Second Affiliated Hospital to Nanchang University, Nanchang · Nanjing Drum Tower hospital, Nanjing · The Second Hospital of Nanjing, Nanjing · Ningbo Second Hospital, Ningbo · General Hospital of Ningxia Medical University, Ningxia · Pingxiang People's Hospital, Pingxiang · QingDao Municipal Hospital, Qingdao · Shanghai General Hospital, Shanghai · Shanghai East Hospital, Shanghai · Huashan Hospital, Fudan University, Shanghai · Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai · Shanghai Public Health Clinical Center, Shanghai · The Sixth People's Hospital of Shenyang, Shenyang · The Third People's Hospital of Shenzhen, Shenzhen · The Fifth People's Hospital of Suzhou, Suzhou · Tianjin Second People's Hospital, Tianjin · Tianjin Third Central Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Renmin Hospital of Wuhan University, Wuhan · Wuxi No. 5 People's Hospital, Wuxi · Second Affiliated Hospital of medical college of Xi'an JiaoTong University, Xi'an · First Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · Yanbian University Hospital, Yanji · Yueyang Central Hospital, Yueyang · Yuncheng Center Hopsital, Yuncheng · Sixth People's Hospital of Zhengzhou, Zhengzhou · The Third People's Hospital of Zhenjiang, Zhenjiang

    Registry updated 2026-10-28

  • NCT06632457

    LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

    Trial Treatment · Phase 3 · Boehringer Ingelheim

    Beijing YouAn Hospital,Capital Medical University, Beijing · Peking University People's Hospital, Beijing · Beijing Tsinghua Changgung Hospital, Beijing · Beijing Ditan Hospital, Capital Medical University, Beijing · Beijing Friendship Hospital, Beijing · The First Hospital of Jilin University, Changchun · Hunan Provincial People's Hospital, Changsha · Changzhou Third People's Hospital, Changzhou Shi · West China Hospital,Sichuan University, Chengdu · Chongqing Three Gorges Central Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Nanfang Hosptial, Guangzhou · Guangzhou First People's Hospital, Guangzhou · Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital, Zhejiang University, Hangzhou · Zhejiang Hospital, Hangzhou · The Affiliated Hospital of Hangzhou Normal University, Hangzhou · The First Hospital Of Jiaxing, Jiaxing · First People's Hospital of Yunnan Province, Kunming · Liaocheng People's Hospital, Liaocheng · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The First Affiliated Hospital of NanChang University, Nanchang · The Second Affiliated Hospital to Nanchang University, Nanchang · Nanjing Drum Tower hospital, Nanjing · The Second Hospital of Nanjing, Nanjing · Nanjing Jiangning Hospital, Nanjing · Ningbo Second Hospital, Ningbo · General Hospital of Ningxia Medical University, Ningxia · Pingxiang People's Hospital, Pingxiang · QingDao Municipal Hospital, Qingdao · Shanghai Public Health Clinical Center, Shanghai · Shanghai East Hospital, Shanghai · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai · Huashan Hospital, Fudan University, Shanghai · Renmin Hospital of Wuhan University, Shanghai · Shanghai General Hospital, Shanghai · Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · The Sixth People's Hospital of Shenyang, Shenyang · The Third People's Hospital of Shenzhen, Shenzhen · The Fifth People's Hospital of Suzhou, Suzhou · Tianjin Third Central Hospital, Tianjin · Tianjin Second People's Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Second Affiliated Hospital of medical college of Xi'an JiaoTong University, Xi'an · First Affiliated Hospital of Xi'an Jiaotong University, Xi'an · Sixth People's Hospital of Zhengzhou, Zhengzhou · The Third People's Hospital of Zhenjiang, Zhenjiang

    Registry updated 2026-10-28

  • NCT07897981

    High-Plant-Protein-Diet or High-Animal-Protein-Diet for Improving Alcoholic Fatty Liver Disease

    Trial Treatment · Phase 1/2 · Li Lab,MD

    Zhejiang Chinese Medical University, Hangzhou

    Registry updated 2026-10-27

  • NCT07237750

    iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss

    Trial Treatment · Liu Yan

    The fifth Medical Center of Chinese PLA General Hospital, Beijing, Beijing

    Registry updated 2026-10-26

  • NCT07884903

    Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks

    Research · Shanxi Bethune Hospital

    Department of Endocrinology, Shanxi Bethune Hospital, Taiyuan

    Registry updated 2026-10-21

  • NCT07878091

    A Phase 2a Study of Kylo-0603 Capsule in Participants With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

    Trial Treatment · Phase 2 · Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

    Beijing Tsinghua Changgung Hospital, Affiliated to Tsinghua University, Beijing

    Registry updated 2026-10-16

  • NCT07165028

    A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Peking University People's Hospital, Beijing · Beijing Ditan Hospital, Beijing · Beijing Friendship Hospital Affiliate of Capital University, Beijing · Beijing YouAn Hospital, Beijing · Hunan Provincial People's Hospital, Changsha · The Second Xiangya Hospital of Central South University, Changsha · Xiangya Hospital Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · The First People's Hospital of Foshan, Foshan · Fujian Medical University Mengchao Hepatobiliary Hospital (Fuzhou Infectious Disease Hospital), Fuzhou · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Southern Medical University Nanfang Hospital, Guangzhou · Guangzhou 8th People's Hospital, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · Guizhou Provincial People's Hospital, Guiyang · Affiliated Hospital of Hangzhou Normal University, Hangzhou · Jinhua Central Hospital, Jinhua · Liaocheng People's Hospital, Liaocheng · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · The Affiliated Hospital of Southwest Medical University, Luzhou · The First affiliated hospital of Nanchang University (Xianghu campus), Nanchang · The Second Affiliated Hospital of Nanchang University, Nanchang · Jiangsu Province Hospital, Nanjing · The First Affiliated Hospital of Nanyang Medical College, Nanyang · The First Affiliated Hospital of Ningbo University, Ningbo · Ningbo 2nd Hospital, Ningbo · Ningbo Medical Center, Ningbo · Pingxiang People's Hospital, Pingxiang · Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai · Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai · Zhongshan Hospital,Fudan University, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · Peking University Shenzhen Hospital, Shenzhen · The Third Hospital of Hebei Medical University, Shijiazhuang · Tianjin People's Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · General Hospital of Ningxia Medical University, Yinchuan · Zhoukou Central Hospital, Zhoukou

    Registry updated 2026-10-08

  • NCT07581951

    A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

    Trial Treatment · Phase 3 · Haisco Pharmaceutical Group Co., Ltd.

    Beijing Tsinghua Changgung Hospital, Beijing

    Registry updated 2026-09-23

  • NCT07718126

    Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

    Trial Treatment · Phase 4 · West China Hospital

    Beijing Friendship Hospital, Capital Medical University, Beijing · West China Hospital,Sichuan University, Chengdu · The First Affiliated Hospital of Chongqing Medical University, Chongqing · Anhui Provincial Hospital(The First Affiliated Hospital of Ustc), Hefei

    Registry updated 2026-09-23

  • NCT07807059

    A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

    Trial Treatment · Phase 1 · Fujian Shengdi Pharmaceutical Co., Ltd.

    Sichuan Provincial People's Hospital, Chengdu

    Registry updated 2026-09-16

  • NCT03635541

    Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease

    Research · Beijing Friendship Hospital

    Beijing Friendship Hospital, Capital Medical University, Beijing

    Registry updated 2026-09-15

  • NCT07462455

    Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

    Trial Treatment · Phase 1 · Xiamen Amoytop Biotech Co., Ltd.

    Beijing Tsinghua Changgeng Hospital, Beijing · Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine, Shanghai · The First Affiliated hospital of Xiamen University, Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

    Registry updated 2026-09-14

  • NCT07803809

    Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

    Trial Treatment · Phase 1 · Shanghai Minwei Biotechnology Co., Ltd

    The First Affiliated Hospital of Yunnan University of Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine), Kunming

    Registry updated 2026-09-08

  • NCT07660848

    A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

    Trial Treatment · Phase 2 · Fujian Shengdi Pharmaceutical Co., Ltd.

    Beijing Tsinghua Changgung Hospital, Beijing · The First Affiliated Hospital of Zhengzhou University, Zhengzhou

    Registry updated 2026-08-26

  • NCT07778719

    Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD

    Trial Treatment · The 95th Hospital of Putian,Putian, Fujian, China

    The Ethics Committee of Putian 95 Hospital, Putian

    Registry updated 2026-08-21

  • NCT07070362

    Digital Early Warning System for Acute Lung Injury in Liver Surgery

    Research · Beijing Tsinghua Chang Gung Hospital

    Peking University International Hospital, Beijing · Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University, Beijing · Southwest Hospital, The First Affiliated Hospital of Army Medical University, Chongqing · Huangdao District People's Hospital of Qingdao, Qingdao

    Registry updated 2026-08-17

  • NCT02863757

    Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

    Research · Humanity and Health Research Centre

    Humanity and Health GI and Liver Centre, Hong Kong

    Registry updated 2026-07-29

  • NCT03190538

    Nonalcoholic Steatohepatitis in Chinese Children

    Research · Humanity and Health Research Centre

    Children's Liver Disease Center, 302 Hospital, Beijing

    Registry updated 2026-07-29

  • NCT07706010

    Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

    Research · The Affiliated Hospital of Hangzhou Normal University

    MingWei Wang, Hanzhou

    Registry updated 2026-07-15

  • NCT07693777

    A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

    Trial Treatment · Phase 3 · Zhejiang Doer Biologics Co., Ltd.

    Zhongshan Hospital, Shanghai

    Registry updated 2026-07-10

  • NCT07682363

    Registry updated 2026-07-02

  • NCT07679542

    Dihydroartemisinin for MAFLD

    Trial Treatment · Phase 1/2 · The First Affiliated Hospital with Nanjing Medical University

    The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, Nanjing

    Registry updated 2026-07-01

  • NCT07640880

    Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV

    Research · Yinzhong Shen

    Shanghai Public Health Clinical Center, Shanghai

    Registry updated 2026-06-11

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Fatty liver disease (MASLD/MASH) trials in China – Frontlight Research